Company / Assets per Share
BioNexus Gene Lab Corp Assets per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$5.15
FY2025
5-year range
$0.05 / $5.15
FY2021-FY2025
Trend
+772.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Assets per Share changed +772% YoY in FY2025, a notable deviation from the 6-year average annual change of +439%.
Based on SEC 10-K filings.
5.15 in FY2025 with a 5-year CAGR of +120.6%.
Improved from $0.79 to $5.15 over the past 2 years.
Assets per Share over time
Growth rates
- 3-Year CAGR
- +365.5%
- 5-Year CAGR
- +120.6%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, assets per share increased 772.0% year-over-year.
- Lowest assets per share in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score 5.27 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5.15 | +772.0% |
| FY2024 | $0.59 | -25.0% |
| FY2023 | $0.79 | +1442.6% |
| FY2022 | $0.05 | -8.7% |
| FY2021 | $0.06 | -43.2% |
| FY2020 | $0.10 | +496.8% |
| FY2019 | $0.02 | - |
As of FY2025 · SEC Form 10-K · Last checked Jun 21, 2026